新型狗肝细胞染色体P450 3A293氧化内源性和雌二醇
Yasuhiro Uno1, Genki Ushirozako1, Norie Murayama2
1Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima-city, Kagoshima 890-0065, Japan.
Biochemical pharmacology
|March 3, 2025
概括
一种新的犬类细胞染色体P450 (CYP) 酶,狗类CYP3A293被确定. 这种酶可以代谢,雌激素,二甲和咖啡因,但不能代谢米达佐拉姆,这为药物开发提供了洞察力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
- 遗传学 是一个遗传学.
背景情况:
- 细胞染色体P450 (CYPs) 对药物代谢至关重要,并且在狗身上进行了广泛的药物开发研究.
- 以前的研究发现了几种狗CYP3A形式,但最近发现了一种新型形式,CYP3A293.
研究的目的:
- 为了分离和描述这只新型狗的CYP3A293cDNA.
- 调查狗CYP3A293.3.的表达模式和代谢活动.
主要方法:
- 狗CYP3A293cDNA的分离和序列分析.
- 遗传学分析以确定其与其他CYP3A形式的关系.
- 在各种狗组织中对CYP3AmRNA表达的定量分析.
- 狗CYP3A293的重组表达,以评估其在各种基质上的酶活性.
- 分子对接模拟用于预测基质-酶相互作用.
主要成果:
- 狗CYP3A293cDNA编码了一种503氨基酸蛋白质,与其他狗CYP3A酶具有很高的相同性.
- 遗传学分析显示,CYP3A293最接近于狗类CYP3A99.
- CYP3A293 mRNA主要在肝脏中表达,CYP3A12是最丰富的CYP3A mRNA.
- 重组犬CYP3A293有效地氧化和雌激素,以及二甲,并去甲基化咖啡因.
- 米达佐拉姆的新陈代谢和由CYP3A293进行的丸素6β-氧化是缓慢的.
结论:
- 狗CYP3A293是第五个已识别的狗CYP3A酶,与人类和其他狗CYP3A基因具有结构相似之处.
- 这种新型酶在代谢内源性类固醇和外源性化合物 (如迪克洛菲纳克和咖啡因) 中发挥作用.
- 狗CYP3A293的有限的米达佐拉姆代谢表明,它可能不是对狗的米达佐拉姆清除的主要贡献者.
相关概念视频
Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
Drug Metabolism: Phase II Reactions
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
Testosterone: Functions and Regulation
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Drug toxicity: Idiosyncratic Reactions
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...


